Android
Nokia
Windows
Published on Mon, May 16, 2011 at 12:00 | Source : Moneycontrol.com
Updated at Mon, May 16, 2011 at 12:05
ALSO READ
Plethico Pharma
BSE | NSE 30/05/12
Plethico Pharma has announced its fourth quarter results. The company's Q4FY11 consolidated revenues were up 5.4% at Rs 354 crore versus Rs 336 crore.
Its PAT was down 23% at Rs 55 crore versus Rs 71 crore.
Its EBITDA margin at 20.1% versus 21.7%.
PREVIOUS STORY
Hold NMDC; target of Rs 171: Nirmal Bang
NEXT STORY
Morgan Stanley gets RBI nod for banking licence
Oppn gears up to make Bharat bandh a success
On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue
May 30 2012, 23:16
Clash of Spain and ECB worrying investors: Verstrate
- in FII View
May 30 2012, 11:18
Result corner: Ajay Bodke`s top bets from across sectors
- in MARKET OUTLOOK
May 30 2012, 17:04 | Source: CNBC-TV18
Margins may be hit on one-off items in EBITDA: Sun Pharma
May 30 2012, 16:32 | Source: CNBC-TV18
Essar announces Rs 175cr deal; to pay-off debts with fund
Subscribe to
Moneycontrol Newsletters
Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!